In addition, the proportion of tumor‐infiltrating CD8+ T cells as well as TNFα+ CD8+ T cells was significantly increased in Cbx1‐knockout tumors (Figure 7L,M), indicating the enhanced CD8+ T‐cell antitumor immune response in Cbx1‐knockout tumors. The gene discussed is CD8A; the disease is neoplasm.